(Q73958643)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10882151%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

title

Long-term treatment with interferon-beta therapy for multiple sclerosis and occurrence of Graves' disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10882151%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10882151%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

author name string

M Rotondi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10882151%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

B Biondi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10882151%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

G Manganella

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10882151%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

A D Del Buono

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10882151%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

P Montella

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10882151%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

M di Cristofaro

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10882151%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

G Di Iorio

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10882151%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

G Amato

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10882151%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

C Carella

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10882151%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

publication date

1 May 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10882151%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

number of pages

4

1 reference

Journal of Endocrinological Investigation

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10882151%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10882151%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10882151%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

page(s)

321-324

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10882151%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf03343730

8 November 2019

exact match

0 references

cites work

Reversibility of thyroid dysfunction induced by recombinant alpha interferon in chronic hepatitis C

1 reference

12 December 2020

Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha

1 reference

12 December 2020

Autoimmune events during interferon beta-1b treatment for multiple sclerosis

1 reference

12 December 2020

Occurrence of thyroid autoimmunity in relapsing remitting multiple sclerosis patients undergoing interferon-beta treatment

1 reference

12 December 2020

Immune-mediated side-effects of cytokines in humans

1 reference

12 December 2020

Effect of interferon-beta on thyroid function in patients of chronic hepatitis C without preexisting autoimmune thyroid disease

1 reference

12 December 2020

No evidence for increased frequency of autoantibodies during interferon-beta1b treatment of multiple sclerosis.

1 reference

12 December 2020

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group

1 reference

12 December 2020

Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-alpha therapy

1 reference

12 December 2020

Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy

1 reference

12 December 2020

Autoimmune hyperthyroidism in patients with multiple sclerosis treated with interferon beta-1b

1 reference

12 December 2020

Autoimmunity in multiple sclerosis

1 reference

12 December 2020

Longitudinal Study of Antibodies against Thyroid in Patients Undergoing Interferon-&alpha; Therapy for HCV Chronic Hepatitis

1 reference

12 December 2020

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

12 December 2020

Occurrence of thyroid autoimmunity and dysfunction throughout a nine-month follow-up in patients undergoing interferon-beta therapy for multiple sclerosis

1 reference

12 December 2020

Effect of 1-year treatment with interferon-beta1b on thyroid function and autoimmunity in patients with multiple sclerosis

1 reference

12 December 2020

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

12 December 2020

Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. The IFNB Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group

1 reference

12 December 2020

Antithyroid antibodies in multiple sclerosis

1 reference

12 December 2020

Does interferon-beta therapy induce thyroid autoimmune phenomena?

1 reference

12 December 2020